MedTrace Logo

Microbiome Determinants of Neurological and Gastrointestinal Symptoms of Autism Spectrum Disorder (ASD)

NCT05465148 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2023-10-17

No results posted yet for this study

Summary

This observational study aims to identify human microbiome determinants of the symptoms associate with ASD as well as identify the human microbiome determinants of the success of FMT (fecal matter transplant) therapy and to develop a statistical model that can improve FMT donor-recipient matching. Participants are recruited through NovelBiome only, this study will NOT utilize other clinical sites.

Conditions

Sponsors & Collaborators

  • Viome

    lead INDUSTRY

Principal Investigators

  • Momchilo Vuyisich · Viome

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-14
Primary Completion
2023-08-16
Completion
2023-08-16

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05465148 on ClinicalTrials.gov